Depletion of activated macrophages with a folate receptor-beta-specific antibody improves symptoms in mouse models of rheumatoid arthritis

OBJECTIVES: Most therapies for autoimmune and inflammatory diseases either neutralize or suppress production of inflammatory cytokines produced by activated macrophages (e.g., TNFα, IL-1, IL-6, IL-17, GM-CSF). However, no approved therapies directly target this activated subset of macrophages. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yingwen, Wang, Bingbing, Shen, Jiayin, Low, Stewart A., Putt, Karson S., Niessen, Hans W. M., Matteson, Eric L., Murphy, Linda, Ruppert, Clemens, Jansen, Gerrit, Oliver, Stephen J., Feng, Yang, Dimitrov, Dimiter S., Nickerson-Nutter, Cheryl, Low, Philip S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555977/
https://www.ncbi.nlm.nih.gov/pubmed/31174578
http://dx.doi.org/10.1186/s13075-019-1912-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555977/
https://www.ncbi.nlm.nih.gov/pubmed/31174578
http://dx.doi.org/10.1186/s13075-019-1912-0

Ejemplares similares